IQ GENETIC TECHNOLOGY LIMITED × HKRM Lab Joint Product
Clinical Cases

Solitary Ground-Glass Nodule Completely Absorbed in 17 Days — A Real Case of Stem Cell Exosome Nebulization

JuvGuard Clinical Team DXY Clinical Report 2026年06月07日 26
A 42-year-old female patient with a solitary ground-glass nodule (approximately 8mm in diameter) in the outer basal segment of the left lower lobe, after 3 months of ineffective anti-inflammatory treatment, underwent umbilical cord mesenchymal stem cell exosome nebulization therapy. The lesion was completely absorbed after 17 days.

Patient Information

Female, 42 years old. A solitary ground-glass nodule of approximately 8mm was discovered during a health checkup in the outer basal segment of the left lower lobe.

Treatment Protocol

Umbilical cord mesenchymal stem cell exosome nebulization, once daily for 17 consecutive days.

Key Timeline

  • Day 0: 8mm ground-glass nodule
  • Day 6: Reduced density, shrank to 5mm
  • Day 17: Lesion completely absorbed

Conclusion

Exosome nebulization enables rapid anti-inflammatory and regenerative effects, completely eliminating an inflammatory ground-glass nodule in just 17 days.

Consult